- Info
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of ELI LILLY & Co
- Signature - Title
- /s/ Christopher Anderson - Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
- Location
- Indianapolis, IN
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by ELI LILLY & Co.
Follow Filing Activity
Follow ELI LILLY & Co and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of ELI LILLY & Co
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTSQ | Aktis Oncology, Inc. | Common Stock, $0.0001 par value per share | 12% | $63,441 | 6,344,114 | Eli Lilly and Company | 12 Jan 2026 | ||
| IMCR | Immunocore Holdings plc | Ordinary Shares | 0% | 0 | ELI LILLY & Co | 30 Sep 2025 |
Schedules 13D/G Reported by ELI LILLY & Co:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.